Related Experiment Video
Updated: Oct 16, 2025

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Phosphoglycerate kinase 1 silencing by a novel microRNA microRNA-4523 protects human osteoblasts from dexamethasone
Jin-Qian Liang1, Zhen-Tao Zhou2, Lin Bo3
1Department of Orthopaedics, Peking Union Medical College Hospital, Beijing, China.
Abstract:
Nuclear-factor-E2-related factor 2 (Nrf2) cascade activation can ameliorate dexamethasone (DEX)-induced oxidative injury and death in human osteoblasts. Phosphoglycerate kinase 1 (PGK1) depletion is shown to efficiently activate Nrf2 signaling by inducing methylglyoxal modification of Kelch-like ECH-associated protein 1 (Keap1). We here identified a novel PGK1-targeting microRNA: microRNA-4523 (miR-4523). RNA fluorescent in situ hybridization, RNA pull-down, and Argonaute-2 RNA immunoprecipitation results confirmed a direct binding between miR-4523 and PGK1 mRNA in primary human osteoblasts and hFOB1.19 osteoblastic cells. Forced overexpression of miR-4523, using a lentiviral construct, robustly decreased PGK1 3'-UTR (untranslated region) luciferase activity and downregulated its expression in human osteoblasts and hFOB1.19 cells. Furthermore, miR-4523 overexpression activated the Nrf2 signaling cascade, causing Keap1-Nrf2 disassociation, Nrf2 protein stabilization, and its nuclear translocation as well as transcription activation of Nrf2-dependent genes (NQO1, GCLC, and HO1) in human osteoblasts. By expressing a UTR-null PGK1 construct, miR-4523 overexpression-induced Nrf2 cascade activation was however largely inhibited. Importantly, DEX-induced reactive oxygen species production, oxidative injury, and cell apoptosis were significantly attenuated by miR-4523 overexpression in human osteoblasts and hFOB1.19 cells. Such actions by miR-4523 were abolished by Nrf2 shRNA or knockout, but mimicked by PGK1 knockout (using CRISPR/Cas9 method). In PGK1 knockout human osteoblasts, miR-4523 overexpression failed to further increase Nrf2 cascade activation and offer osteoblast cytoprotection against DEX. Significantly, miR-4523 is downregulated in human necrotic femoral head tissues of DEX-taking patients. Together, PGK1 silencing by miR-4523 protected human osteoblasts from DEX through activation of the Nrf2 signaling cascade.
Insights
MicroRNA-4523 (miR-4523) protects human osteoblasts from dexamethasone (DEX) by targeting phosphoglycerate kinase 1 (PGK1). This activates the Nrf2 pathway, reducing oxidative stress and cell death, offering a novel therapeutic strategy.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Dexamethasone (DEX) induces oxidative injury and apoptosis in human osteoblasts.
- Nuclear-factor-E2-related factor 2 (Nrf2) activation can protect against DEX-induced damage.
- Phosphoglycerate kinase 1 (PGK1) depletion activates Nrf2 signaling.
Purpose of the Study:
- To identify and characterize a novel microRNA targeting PGK1.
- To investigate the role of this microRNA in activating the Nrf2 cascade.
- To determine if this microRNA can protect osteoblasts from DEX-induced injury.
Main Methods:
- RNA fluorescent in situ hybridization, RNA pull-down, and Argonaute-2 RNA immunoprecipitation to confirm miR-4523 and PGK1 interaction.
- Lentiviral constructs for miR-4523 overexpression and PGK1 knockout (CRISPR/Cas9).
- Assessment of Nrf2 signaling activation, gene expression (NQO1, GCLC, HO1), reactive oxygen species production, and cell apoptosis.
Main Results:
- MicroRNA-4523 (miR-4523) directly binds to PGK1 mRNA, downregulating PGK1 expression in osteoblasts.
- miR-4523 overexpression activates the Nrf2 cascade by promoting Keap1-Nrf2 disassociation and Nrf2 nuclear translocation.
- miR-4523 significantly attenuates DEX-induced oxidative stress, injury, and apoptosis, an effect dependent on Nrf2 and PGK1.
- miR-4523 is downregulated in human osteonecrosis tissues from DEX-treated patients.
Conclusions:
- PGK1 silencing by miR-4523 protects human osteoblasts against DEX-induced damage via Nrf2 pathway activation.
- miR-4523 represents a potential therapeutic target for preventing DEX-induced osteotoxicity.
More Related Videos
Related Concept Videos
MicroRNAs
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway

